| The structure and function of telomerase reverse transcriptase C Autexier, NF Lue Annu. Rev. Biochem. 75, 493-517, 2006 | 547 | 2006 |
| Telomerase and cancer: revisiting the telomere hypothesis C Autexier, CW Greider Trends in biochemical sciences 21 (10), 387-391, 1996 | 258 | 1996 |
| A platinum supramolecular square as an effective G-quadruplex binder and telomerase inhibitor R Kieltyka, P Englebienne, J Fakhoury, C Autexier, N Moitessier, ... Journal of the American Chemical Society 130 (31), 10040-10041, 2008 | 215 | 2008 |
| Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing FM Boisvert, J Côté, MC Boulanger, P Cléroux, F Bachand, C Autexier, ... The Journal of cell biology 159 (6), 957-969, 2002 | 193 | 2002 |
| Telomerase, senescence and ageing M Shawi, C Autexier Mechanisms of ageing and development 129 (1-2), 3-10, 2008 | 177 | 2008 |
| Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions F Bachand, C Autexier Molecular and cellular biology 21 (5), 1888-1897, 2001 | 172 | 2001 |
| Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. C Autexier, R Pruzan, WD Funk, CW Greider The EMBO journal 15 (21), 5928-5935, 1996 | 171 | 1996 |
| Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit TJ Moriarty, S Huard, S Dupuis, C Autexier Molecular and cellular biology 22 (4), 1253-1265, 2002 | 142 | 2002 |
| Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer TJ Moriarty, DT Marie-Egyptienne, C Autexier Molecular and cellular biology 24 (9), 3720-3733, 2004 | 137 | 2004 |
| Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment RJ Ward, C Autexier Molecular pharmacology 68 (3), 779-786, 2005 | 126 | 2005 |
| The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity S Huard, TJ Moriarty, C Autexier Nucleic acids research 31 (14), 4059-4070, 2003 | 120 | 2003 |
| Functional reconstitution of wild-type and mutant Tetrahymena telomerase. C Autexier, CW Greider Genes & development 8 (5), 563-575, 1994 | 118 | 1994 |
| Boundary elements of the Tetrahymena telomerase RNA template and alignment domains. C Autexier, CW Greider Genes & development 9 (18), 2227-2239, 1995 | 116 | 1995 |
| A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT MA Cerone, C Autexier, JA Londono-Vallejo, S Bacchetti Oncogene 24 (53), 7893-7901, 2005 | 88 | 2005 |
| A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT MA Cerone, C Autexier, JA Londono-Vallejo, S Bacchetti Oncogene 24 (53), 7893-7901, 2005 | 88 | 2005 |
| The Product of the Survival of Motor Neuron(SMN) Gene is a Human Telomerase-associated Protein F Bachand, FM Boisvert, J Coˆté, S Richard, C Autexier Molecular biology of the cell 13 (9), 3192-3202, 2002 | 86 | 2002 |
| Human telomerase RNA–protein interactions F Bachand, I Triki, C Autexier Nucleic acids research 29 (16), 3385-3393, 2001 | 84 | 2001 |
| Functional Reconstitution of Human Telomerase Expressed inSaccharomyces cerevisiae F Bachand, C Autexier Journal of Biological Chemistry 274 (53), 38027-38031, 1999 | 77 | 1999 |
| Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells MA Cerone, JA Londoño-Vallejo, C Autexier Molecular cancer therapeutics 5 (7), 1669-1675, 2006 | 74 | 2006 |
| An Anchor Site–Type Defect in Human Telomerase That Disrupts Telomere Length Maintenance and Cellular Immortalization TJ Moriarty, RJ Ward, MAS Taboski, C Autexier Molecular biology of the cell 16 (7), 3152-3161, 2005 | 71 | 2005 |
